(HealthDay companies News) — Here are the latest clinical trials, courtesy of CenterWatch:

Partial Medial Meniscectomy

The primary objective of this study is to evaluate the safety of the SIS Meniscal Implant in patients following partial medial meniscectomy, and to evaluate the proportion of patients with evidence of tissue regrowth. Participants must be 18 to 55 years of age (inclusive) with a preoperative clinical evaluation that suggests the presence of an isolated primary medial meniscal tear not requiring concurrent ACL repair. Research site located in Indianapolis, Ind.

More Information

Please see http://www.centerwatch.com/patient/studies/cat711.html.

—–

HIV

This research study is for patients who are HIV-positive and are already taking an anti-HIV medication. There are two sets of therapies in this study: FPV (Fosamprenavir, Lexiva, Telzir) and RTV (Ritonavir, Norvir); all patients in this study will receive medication. You may be eligible if you are 18-65 years old, are HIV positive, and are currently taking an anti-HIV medication. Research site located in New York, NY.

More Information

Please seo services see http://www.centerwatch.com/patient/studies/cat417.html.

—–

Erectile Dysfunction

Carolinas Research Associates is conducting a clinical trial to study the safety and effectiveness of an investigational medication to treat erectile dysfunction. To qualify for this 16-week trial, you must be a male between the ages of 21 and 70, have a stable sexual relationship with only one female partner, and have symptoms of ED for at least six months prior to study participation. Research site located in Charlotte, NC.

More Information

Please see http://www.centerwatch.com/patient/studies/cat371.html.

—–

Copyright 2005 CenterWatch. All rights reserved.